Carl T.
- Country
- Sweden
- Department
- Department of Rheumatology
Research Overview
Data & Insights
Has run more than one trial at 0 of 9 partner sites.
Specializations
Inflammatory Rheumatic Disease
Rheumatoid arthritis, giant cell arteritis, IgG4-related disease, systemic vasculitis, and systemic sclerosis form a central part of the investigator’s clinical research profile. The portfolio also includes rheumatoid arthritis-associated interstitial lung disease and other inflammatory rheumatic diseases.
- Rheumatoid arthritis
- Giant cell arteritis
- Systemic sclerosis
- IgG4-related disease
- Systemic vasculitis
Therapeutic interests extend across immunomodulatory treatment, glucocorticoid-sparing strategies, and interventions aimed at controlling inflammatory disease activity and preventing organ damage.
Autoimmune and Immune-Mediated Kidney Disease
The investigator is involved in studies of anti-GBM antibody disease, ANCA-associated vasculitis, focal segmental glomerulosclerosis, C3 glomerulopathy, proteinuria, and chronic kidney disease, reflecting a strong focus on immune-driven renal injury.
- Anti-GBM antibody disease
- ANCA-associated vasculitis
- Focal segmental glomerulosclerosis
- C3 glomerulopathy
- Chronic kidney disease
Research activity also touches on kidney protection, renal inflammation, and therapies aimed at preserving function in complex autoimmune disorders.
Hematologic Malignancies
A major therapeutic area is hematologic cancer, including multiple myeloma, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, mantle cell lymphoma, Hodgkin lymphoma, and myelodysplastic syndromes.
- Multiple myeloma
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Myelodysplastic syndromes
- Hodgkin lymphoma
The clinical landscape includes interest in novel immunotherapy, cellular therapy, and treatment approaches for relapsed or refractory blood cancers.
Cardiovascular and Metabolic Disease
Research involvement also spans heart failure, atherosclerotic cardiovascular disease, coronary artery disease, atrial fibrillation, dyslipidemia, and type 2 diabetes, with additional interest in stroke prevention and hypertension.
- Heart failure
- Atherosclerotic cardiovascular disease
- Coronary artery disease
- Type 2 diabetes
- Stroke prevention
Therapeutic interests include cardiovascular risk reduction, metabolic control, and approaches to limiting complications in patients with overlapping cardiac and renal disease.
Neurologic and Other Immune-Mediated Conditions
The investigator’s portfolio further includes Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, fibromyalgia, asthma, and ulcerative colitis, showing engagement across neurologic, respiratory, and gastrointestinal immune-mediated disorders.
- Alzheimer’s disease
- Parkinson’s disease
- Multiple sclerosis
- Asthma
- Ulcerative colitis
Additional therapeutic interests include neurodegenerative disease, airway inflammation, and immune-mediated symptom control in chronic multisystem conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.